EULAR Annual European Congress of Rheumatology 2017
Join us at EULAR Congress 2017 in Madrid, 14-17 June
We are delighted to be attending and presenting at this year’s EULAR Annual European Congress of Rheumatology in June. Representing Research Partnership at the event is new Head of Therapy Watch Helen Parfitt who recently joined our UK head office in London and Osato Agbontaen from our business development team. They’ll be on hand to answer any questions that delegates may have about our syndicated market tracking tool Therapy Watch.
If you are attending EULAR 2017 please stop by our presentation in the poster area between 11:45-13:30 on Friday 16th June where we will be sharing insights from our rheumatoid arthritis tracking programme which has now been running since 2008. Our poster looks into the use of biosimilars among European rheumatologists and their potential impact on patient outcomes. Alternatively if you would like to meet us at the event please contact us and we will be happy to arrange a suitable time to meet that’s convenient for you.
About our poster
Poster presentation: FRI0760-HPR
Friday 16th June, 11:45-13:30
Biosimilar use among European Rheumatoid Arthritis patients and impact on patient outcomes.
Biosimilars offers the opportunity for significant cost savings for national health services and the aim of this research is to better understand their use among European rheumatologists and their potential impact on patient outcomes. Written by Therapy Watch Research Director Laurent Chanroux, the poster uses patient record data from 9,650 patients collected as part of an online treatment survey conducted among a panel of 261 rheumatologists between January and December 2016 across 5 European markets (France, Germany, Italy, Spain and the UK).
About Therapy Watch
Therapy Watch is a syndicated market tracking tool that provides marketing teams, brand managers and market researchers with strategic and tactical market information. Run entirely online to ensure speed, quality and up-to-date access to the very latest market data, Therapy Watch offers a clear advantage by putting you in closer contact with your market than ever before. The Therapy Watch Autoimmune portfolio also includes data covering Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA), nr-axial SpA, and Lupus (SLE).